[HTML][HTML] Gut microbiota and atherosclerosis—focusing on the plaque stability

X Shen, L Li, Z Sun, G Zang, L Zhang… - Frontiers in …, 2021 - frontiersin.org
Cardiovascular diseases (CVDs) are major causes of mortality and morbidity in the modern
society. The rupture of atherosclerotic plaque can induce thrombus formation, which is the …

Wearable and implantable artificial kidney devices for end‐stage kidney disease treatment: Current status and review

T Groth, BG Stegmayr, SR Ash, J Kuchinka… - Artificial …, 2023 - Wiley Online Library
Background Chronic kidney disease (CKD) is a major cause of early death worldwide. By
2030, 14.5 million people will have end‐stage kidney disease (ESKD, or CKD stage 5), yet …

Role of the microbiota in hypertension and antihypertensive drug metabolism

E Mishima, T Abe - Hypertension Research, 2022 - nature.com
Recent evidence suggests that the gut microbiota plays an important role in the
development and pathogenesis of hypertension. Dysbiosis, an imbalance in the composition …

[HTML][HTML] Biotics (Pre-, pro-, post-) and uremic toxicity: implications, mechanisms, and possible therapies

L Mitrea, M Medeleanu, CR Pop, AM Rotar, DC Vodnar - Toxins, 2023 - mdpi.com
In recent years, more scientific data have pointed out the close connection between
intestinal microbial community, nutritional habits, lifestyle, and the appearance of various …

[HTML][HTML] Hypomagnesemia as a risk factor and accelerator for vascular aging in diabetes mellitus and chronic kidney disease

ÁG Pethő, M Tapolyai, M Browne, T Fülöp - Metabolites, 2023 - mdpi.com
The age-old axiom that one is as old as his or her vessels are, calls for ongoing critical re-
examination of modifiable risk factors of accelerated vascular ageing in chronic kidney …

[HTML][HTML] Uremic toxins and frailty in patients with chronic kidney disease: a molecular insight

CT Chao, SH Lin - International journal of molecular sciences, 2021 - mdpi.com
The accumulation of uremic toxins (UTs) is a prototypical manifestation of uremic milieu that
follows renal function decline (chronic kidney disease, CKD). Frailty as a potential outcome …

[HTML][HTML] Phosphate, microbiota and CKD

C Favero, S Carriazo, L Cuarental, R Fernandez-Prado… - Nutrients, 2021 - mdpi.com
Phosphate is a key uremic toxin associated with adverse outcomes. As chronic kidney
disease (CKD) progresses, the kidney capacity to excrete excess dietary phosphate …

[HTML][HTML] Contribution of gut microbiota-derived uremic toxins to the cardiovascular system mineralization

I Filipska, A Winiarska, M Knysak, T Stompór - Toxins, 2021 - mdpi.com
Chronic kidney disease (CKD) affects more than 10% of the world population and leads to
excess morbidity and mortality (with cardiovascular disease as a leading cause of death) …

[HTML][HTML] Gender-related differences in chronic kidney disease-associated vascular calcification risk and potential risk mediators: a scoping review

PY Wu, SY Lee, KV Chang, CT Chao, JW Huang - Healthcare, 2021 - mdpi.com
Vascular calcification (VC) involves the deposition of calcium apatite in vascular intima or
media. Individuals of advanced age, having diabetes mellitus or chronic kidney disease …

Vascular frailty, a proposal for new frailty type: A narrative review

CT Chao, KY Hung - The Kaohsiung Journal of Medical …, 2023 - Wiley Online Library
Frailty is the incremental accumulation of minute defects that progressively impair health and
performance. Frailty is commonly observed in older adults; however, secondary frailty may …